Can only go on for so long. Hopefully management can find an EU deal quick that will get this going north to $1.40, and then when the revenues starting coming in well the sky is the limit.
You gotta love it when you are invested in a company that has a product that no one else has, vivagel seems like a product that has been needed for a while now.
Good luck to all holding, this rockets ship is starting to warm up real quick.
As all ways DYOR.
Ann: Mundipharma licenses Starpharma's VivaGel BV, page-44
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
